Reneuron Share Discussion Threads

[fredd1eboy] 06/8/2017 11:19

Spot on nw

[nw99] 06/8/2017 08:53

Interesting cash on Bal sheet = mkt cap could be a big winner

[bean02] 04/8/2017 16:21

Massive volume spike

[small crow] 04/8/2017 15:29

About time ...

[127tolmers] 04/8/2017 14:39

Extract from today's report. My sentiments exactly.



By way of example, ReNeuron, a leading clinical stage stem cell business, had a market capitalisation at period end of £54m. At its latest financial year end (31 March 2017), the company held £53m in cash on its balance sheet, meaning that the stock market is effectively ascribing a value of £1m to the future value of this company's world-class technology. This appears ludicrous, in my view, but it also serves as an effective demonstration of how market inefficiencies can lead to compelling long-term investment opportunities.

[norbus] 02/8/2017 12:05

I really feel for you guys as a past holder who saw enough to be disillusioned and sold out.

Please do not say that rocket fuel or myself for that matter did not raise a red flag over the moral fibre of the controlling people behind this company; The price is discounting the cash by liabilities when a premium is deserved if they have not lied to you

[fredd1eboy] 02/8/2017 10:00

Its a disgrace. Poor Reneuron management has allowed the share price to drop to this ridiculous level.
Olav Hellebo with is over inflated salary should be sacked, unless he leads a recovery.
At this sp, when we do go for a cash call, we will be ravaged. Get your act together Olav and earn your salary.

[alphapig] 02/8/2017 09:25

Over 3 billion shares in issue and it drops on that?

[127tolmers] 31/7/2017 11:11

Interesting yes, but old. Does not contain early Ph2 results which improve conclusions. See recent Proactiv presentations.

[fredd1eboy] 29/7/2017 16:50

Interesting article

[small crow] 27/7/2017 08:14

Related news:

[norbus] 26/7/2017 14:03

No placing; Shake up the register and wake up the dead.

[127tolmers] 25/7/2017 18:34

New joint broker = placing?

[dickbush] 05/7/2017 18:30

Out all day and missed one of the few up days.

[yachtmaster2] 05/7/2017 17:21

Good god. It's going up. 0.4p a share up on my last purchase.

[dickbush] 04/7/2017 08:51

Thanks,algernon2

A very professional and positive presentation. However, he and the company seem to continue to have a major credibility problem-as judged by the share price. Despite record highs for the stockmarket, the share price is at an all-time low with holders, apparently, willing to sell no matter what the bid price.

[algernon2] 03/7/2017 20:59

"It's 'all systems go' as ReNeuron gears up for Phase III stroke disability study"

[dennisbergkamp] 29/6/2017 18:24

Seems like all tech shares are being hit by a bubble in some... D

[dickbush] 29/6/2017 18:21

Agreed, Verger.

I'm not sure, as the presentation claims, that they are ahead of competition in all of their areas of interest. However, it was a good presentation, I thought, although my level of expertise in biotec is minimal.

The shares are my speculation in an exciting area. I know what the downside is!

[verger] 29/6/2017 18:06

Or you could say that no value is being given to its potential. This is silly.

[dickbush] 29/6/2017 17:35

Shares being valued at its cash. No value, therefore, being assigned to all the clinical work that has taken place so far.

[dogwalker] 29/6/2017 10:22

'Results' are a list of projects being worked on. The real news - or results really - come at times when they discover something or someone offers money.
The consequence of today's RNS , so far, is that the share price trajectory is maintaining its 'going down the drain' path.Of course that can change suddenly, & I certainly hope it will .